<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01436058</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-Bone-007</org_study_id>
    <nct_id>NCT01436058</nct_id>
  </id_info>
  <brief_title>Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Ankle Joint Osteoartritis</brief_title>
  <official_title>Phase 1 Study of Side Effects of Autologous Mesenchymal Stem Cell Transplantation in Patients With Ankle Joint Osteoarteritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ankle osteoarthritis is a joint condition which results from damage and loss of the cartilage
      in a joint. Treatment options for ankle osteoarthritis are usually aimed at controlling pain
      and limiting motion that provokes the pain. Nonsurgical treatment approaches are tried first.
      If unsuccessful, surgical options are considered. Stem cell therapy is one of the therapeutic
      options that can repair the damaged cartilage. Bone marrow derived mesenchymal stem cells
      have showed the capacity of bone and cartilage regeneration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this clinical study the investigators aim to investigate the safety of intra-articular
      injection of cultured autologous bone marrow derived mesenchymal stem cells (BM-MSCs) to the
      ankle joint in patients with severe ankle osteoarthritis. Patients will undergo bone marrow
      aspiration and will receive cultured BM-MSCs one month later. Patients will be assessed
      clinically with scoring system (FAO, VAS, WOMAC) preoperatively as well as 2 and 6 months
      postoperative to measure pain reduction and joint function improvement. Paraclinical studies
      (X-Ray and MRI) will be performed before and 6 months after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>safety</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluate Safety of intra-articular injection of autologous cultured mesenchymal stem cells in patients with ankle osteoarthritis (time frame : baseline, 2 months, 6 months)by filling the check list of side effects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>6 months</time_frame>
    <description>evaluation the pain reduction in patients with ankle joint osteoarthritis after stem cell transplantation by filling the SF36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical function</measure>
    <time_frame>6 months</time_frame>
    <description>evaluation the ability of patient to standing,walking,climb the steps after stem cell transplantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>defect</measure>
    <time_frame>6 months</time_frame>
    <description>evaluation regeneration of ankle joint by serial MRI after stem cell transplantation based on changing the size of articular defect</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>stem cell recipient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with ankle joint osteoarthritis</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>mesenchymal stem cell</intervention_name>
    <description>intraarticular injection of mesenchymal stem cell in patients with ankle joint osteoarthritis</description>
    <arm_group_label>stem cell recipient</arm_group_label>
    <other_name>stem cell transplantation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthritis diagnosed by MRI

          -  End stage osteoarthritis candidate for total ankle replacement

        Exclusion Criteria:

          -  Pregnancy or lactating

          -  Positive tests for HIV, HCV, HBV

          -  Active neurologic disorder

          -  End organ damage

          -  Uncontrolled endocrine disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hamid Gourabi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Head of Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nasser Aghdami, MD,PhD</last_name>
    <role>Study Director</role>
    <affiliation>Head of Royan Cell therapy Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohsen Emadeddin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>orthopedic scientists</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royan Institute</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://www.royaninstitute.org/cmsen/index.php</url>
  </link>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2011</study_first_submitted>
  <study_first_submitted_qc>September 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2011</study_first_posted>
  <last_update_submitted>September 16, 2011</last_update_submitted>
  <last_update_submitted_qc>September 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>side effect</keyword>
  <keyword>mesenchymal stem cell</keyword>
  <keyword>ankle</keyword>
  <keyword>osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

